ARWR vs PRAX: stock comparison and AI forecast
Arrowhead Pharmaceuticals, Inc. (ARWR) and Praxis Precision Medicines, Inc. (PRAX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ARWR Arrowhead Pharmaceuticals, Inc.
- Market Cap
- $8.54B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
PRAX Praxis Precision Medicines, Inc.
- Market Cap
- $7.65B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ARWR is 1.1 times larger than PRAX by market capitalization ($8.54B against $7.65B).
- ARWR carries 3.54 times debt per unit of equity, against 0.04 times for PRAX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ARWR | PRAX |
|---|---|---|
| Market Cap | $8.54B | $7.65B |
| P/B Ratio | 18.35x | 5.70x |
| EPS | $-1.47 | $-12.95 |
| Book Value/Share | $3.30 | $48.03 |
| Revenue/Share | $6.63 | – |
| FCF/Share | $-0.53 | $-10.94 |
Profitability & Margins
| Metric | ARWR | PRAX |
|---|---|---|
| ROE | – | -25.3% |
| ROA | – | -24.4% |
| ROIC | -12.4% | -28.2% |
| Operating Margin | -24.2% | – |
| EBT Margin | -26.9% | – |
| Tax Rate | -8.0% | – |
Financial Health
| Metric | ARWR | PRAX |
|---|---|---|
| Current Ratio | 5.90x | 15.73x |
| D/E Ratio | 3.54x | 0.04x |
| Financial Leverage | 4.54x | 1.04x |
| Interest Coverage | -2321.4x | – |
| Working Capital | $1.39B | $723M |
Cash Flow
| Metric | ARWR | PRAX |
|---|---|---|
| Operating Cash Flow | -$59M | -$305M |
| Free Cash Flow | -$75M | -$305M |
| Capital Spending | -$16M | -$310K |
| OCF Growth YoY | -370.3% | – |
| FCF/Sales | -8.0% | – |
| CapEx/Sales | 1.7% | – |
Operational Efficiency
| Metric | ARWR | PRAX |
|---|---|---|
| Asset Turnover | 0.44x | – |
| Receivables Turnover | 109.4x | – |
| Fixed Assets Turnover | 2.5x | – |
| Days Sales Outstanding | 3 days | – |
Income Statement
| Metric | ARWR | PRAX |
|---|---|---|
| Total Revenue | $936M | – |
| Operating Income | -$226M | -$378M |
| Net Income | – | -$339M |
| R&D Expense | $723M | $291M |
Dividend & Shareholder Information
| Metric | ARWR | PRAX |
|---|---|---|
| Shares Outstanding | 141M | 28M |
ARWR vs PRAX: stock comparison and AI forecast
Which is bigger, ARWR or PRAX?
ARWR is 1.1 times larger than PRAX by market capitalization ($8.54B against $7.65B).
Which one does Intratio's AI model rank higher, ARWR or PRAX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.